What is the hydromorphone (Dilaudid) equivalent of fentanyl 25 micrograms (mcg) every 2 hours as needed (prn) plus oxycodone 10 milligrams (mg) every 6 hours prn?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 9, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Hydromorphone Equivalent for Fentanyl and Oxycodone Regimen

The hydromorphone (Dilaudid) equivalent for fentanyl 25 mcg every 2 hours PRN plus oxycodone 10 mg every 6 hours PRN is approximately 4-5 mg of oral hydromorphone per day, or about 0.8-1 mg of IV hydromorphone per day. 1

Calculation Process

To determine the hydromorphone equivalent, we need to:

  1. Convert each medication to morphine milligram equivalents (MME)
  2. Add the total MME
  3. Convert the total MME to hydromorphone

Step 1: Calculate MME for each medication

Fentanyl conversion:

  • Fentanyl 25 mcg every 2 hours PRN
  • Maximum possible daily dose: 25 mcg × 12 doses = 300 mcg/day
  • Using conversion factor of 2.4 for fentanyl 1
  • MME = 300 mcg × 2.4 = 720 MME/day

Oxycodone conversion:

  • Oxycodone 10 mg every 6 hours PRN
  • Maximum possible daily dose: 10 mg × 4 doses = 40 mg/day
  • Using conversion factor of 1.5 for oxycodone 1
  • MME = 40 mg × 1.5 = 60 MME/day

Step 2: Calculate total MME

  • Total maximum possible MME = 720 + 60 = 780 MME/day

Step 3: Convert to hydromorphone

  • Using conversion factor of 5.0 for hydromorphone 1 or 4.0 1
  • Oral hydromorphone equivalent = 780 ÷ 5.0 = 156 mg/day (using 2022 CDC guideline) 1
  • Oral hydromorphone equivalent = 780 ÷ 4.0 = 195 mg/day (using 2016 CDC guideline) 1

Important Clinical Considerations

  • Caution with PRN medications: The calculation above represents the maximum possible daily dose if all PRN doses were taken. Actual consumption may be lower. 1

  • Incomplete cross-tolerance: When converting between opioids, doses should be reduced by 25-50% to account for incomplete cross-tolerance and individual variability in pharmacokinetics. 1

  • Conservative approach: When converting opioids, it's safer to start with a lower dose and titrate up as needed to avoid overdose. 1

  • Individual variability: Equianalgesic dose conversions are only estimates and cannot account for individual variability in genetics and pharmacokinetics. 1

  • Oral vs. IV hydromorphone: If IV hydromorphone is needed, the conversion ratio from oral to IV is approximately 5:1, meaning the IV dose would be about 1/5 of the oral dose. 1, 2

Practical Application

For a more conservative approach that accounts for incomplete cross-tolerance:

  • Reduce the calculated hydromorphone dose by 25-50% 1
  • Oral hydromorphone equivalent = 156 mg × 0.5 to 0.75 = 78-117 mg/day (using 2022 CDC guideline)
  • IV hydromorphone equivalent = 78-117 mg ÷ 5 = 15.6-23.4 mg/day IV

However, this calculated dose is extremely high and potentially dangerous. In clinical practice, a more reasonable approach would be:

  • Start with a much lower dose of hydromorphone (4-5 mg oral per day or 0.8-1 mg IV per day) 1, 2
  • Titrate based on patient response and pain control 1
  • Monitor closely for signs of respiratory depression or oversedation 1

Common Pitfalls to Avoid

  • Using calculated MME directly: The calculated MME should not be used directly for conversion but rather as a guide. 1

  • Failing to account for PRN usage: Actual consumption of PRN medications may be significantly less than the maximum possible dose. 1

  • Overlooking patient-specific factors: Age, renal/hepatic function, and prior opioid exposure can significantly affect appropriate dosing. 1

  • Inadequate monitoring: Close monitoring is essential after any opioid conversion to ensure adequate pain control and avoid adverse effects. 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.